Boosting Bispecific Antibody Yields with >98% Purity

Bispecific antibodies (bsAbs) are shaping the future of therapeutics, but challenges like limited throughput, low yields, and chain mispairing across diverse formats can slow progress.

This white paper shares practical strategies and real-world case studies to help you tackle these hurdles. Discover how…